Moxidectin, Pyrantel Pamoate, Sarolaner Patent Expiration


About Veterinary Moxidectin, Pyrantel Pamoate, Sarolaner

Moxidectin, Pyrantel Pamoate, Sarolaner is used in a drug marketed by 1 company: Zoetis Inc.

Other drugs containing Moxidectin, Pyrantel Pamoate, Sarolaner are: Simparica trio .

Veterinary Moxidectin, Pyrantel Pamoate, Sarolaner Patents

Given below is the list of patents protecting Moxidectin, Pyrantel Pamoate, Sarolaner, along with the drug name that holds that patent and the company owning that drug.

Filter patents by

Drug Used In Drug Patent Number Drug Patent Expiry Drug Owner
Patent Data
Simparica TRIO US8466115 08 Mar, 2032 ZOETIS INC.
Simparica TRIO US9226928 08 Mar, 2032 ZOETIS INC.

Moxidectin, Pyrantel Pamoate, Sarolaner's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Moxidectin, Pyrantel Pamoate, Sarolaner Generic API Manufacturers

Given below is the list of companies who have filed for Moxidectin, Pyrantel Pamoate, Sarolaner generic, along with the locations of their manufacturing plants worldwide.